dr. reid merryman discusses a study of checkpoint inhibitors prior to stem cell transplant
Published 4 years ago • 375 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
1:22
dana-farber cancer institute: reid merryman, md ash 2020
-
2:02
roman shapiro, md, stem cell transplant physician | dana-farber cancer institute
-
40:44
iach journal club allogeneic transplantation after pd 1 blockade for classic hodgkin lymphoma
-
1:59
topics of interest in mds: the role of maintenance therapy, immune checkpoints & ven-aza in hr-mds
-
3:48
reflections on working at dana-farber cancer institute
-
1:02:19
immune checkpoint inhibition and novel therapies for myelodysplastic syndromes/neoplasms
-
2:38
dr reid merryman | ash 2017 | what is the role of different immunotherapies in dlbcl?
-
1:05:04
biology of lymphoma presented by dr samar issa
-
1:13
dr. glaucomflecken (ophthalmologist, comedian): em residency graduation 2020 video
-
52:45
current treatment options - stephen ansell, md
-
48:04
dr. prodromos stem cell faq lecture - jan 2022
-
36:16
genomics – adam bass, md, harvard dana-farber cancer institute
-
8:00
genmab and abbvie present new epcoritamab data at eha 2023
-
33:56
the promise study: how a blood test can detect, intercept, and potentially eliminate cancer
-
3:48
mrd-driven hsct for all
-
2:28
endometrial cancer research updates | dana-farber cancer institute
-
1:37
jeffrey a. meyerhardt, md, mph, medical oncologist, dana-farber cancer institute
-
44:36
lymphoma treatment and evolution
-
57:50
dr. peter gilbert: immune correlates analysis of the mrna-1273 vaccine efficacy trial
-
21:21
inflammasome activation in acute covid-19 - judy lieberman, md, phd
-
1:28
immune checkpoint inhibitors and sitravatinib in bladder cancer
-
7:24
greater cancer care is well-connected healthcare